# MAP3K19

## Overview
MAP3K19 is a gene that encodes the protein mitogen-activated protein kinase kinase kinase 19, a serine/threonine kinase involved in critical cellular signaling pathways. This kinase is a part of the mitogen-activated protein kinase (MAPK) signaling cascade, which plays a pivotal role in regulating cellular responses to stress, inflammation, and other external stimuli (Sandhu2023MAP3K19). MAP3K19 is predominantly expressed in specific cell types within the lung, including alveolar and interstitial macrophages, bronchial epithelial cells, and type II pneumocytes, where it is implicated in the cellular response to environmental stressors (Boehme2017P3.01054; Boehme2016MAP3K19). The protein is known to modulate pathways such as ERK and JNK by phosphorylating upstream MAP2Ks, thereby influencing processes like cell survival and inflammation (Hoang2020The). Given its involvement in these pathways, MAP3K19 has been identified as a potential therapeutic target in diseases such as cancer and chronic obstructive pulmonary disease (COPD), where it contributes to pathological signaling and inflammatory responses (Boehme2016MAP3K19; Liu2023CC).

## Function
MAP3K19, also known as mitogen-activated protein kinase kinase kinase 19, is a serine/threonine protein kinase involved in various cellular signaling pathways. In healthy human cells, MAP3K19 is predominantly localized to alveolar and interstitial macrophages, bronchial epithelial cells, and type II pneumocytes of the epithelium (Boehme2017P3.01054). It is transcriptionally upregulated in response to different types of cell stress, including oxidative, endoplasmic reticulum, and osmotic stress, suggesting a role in stress response mechanisms (Boehme2017P3.01054; Boehme2016MAP3K19).

MAP3K19 is involved in the MAPK signaling pathway, which regulates various cellular activities, including inflammation and stress responses (Sandhu2023MAP3K19). It has been shown to suppress ERK phosphorylation and induce MKP-1 expression, indicating its involvement in signaling pathways that regulate epithelial responses to external stimuli (Sandhu2023MAP3K19). The kinase is also implicated in the regulation of NF-κB activity, a key transcription factor involved in inflammation (Boehme2016MAP3K19).

In the context of lung health, MAP3K19 is expressed in ciliated bronchial epithelial cells, alveolar and interstitial macrophages, and some type II pneumocytes, playing a role in the cellular response to environmental stressors (Boehme2016MAP3K19). However, the specific function of MAP3K19 in healthy human cells remains to be fully elucidated.

## Clinical Significance
MAP3K19 has been implicated in several diseases due to its role in cellular signaling pathways. In cancer, MAP3K19 is a critical regulator of the MAPK signaling pathway, particularly in KRAS-mutant lung cancer cells, where it supports cell survival and proliferation. Its depletion reduces cell viability and decreases ERK and JNK pathway activation, suggesting its potential as a therapeutic target in RAS-mutant cancers (Hoang2020The). MAP3K19 is also overexpressed in ovarian cancer cells, where it promotes proliferation, migration, and invasion, indicating its role in cancer progression (Liu2023CC).

In chronic obstructive pulmonary disease (COPD), MAP3K19 is overexpressed and acts as a central mediator of cigarette smoke-induced pulmonary inflammation and airway destruction. It induces the expression of pro-inflammatory chemokines and activates the NF-κB pathway, contributing to the inflammatory response in COPD (Boehme2016MAP3K19). In idiopathic pulmonary fibrosis (IPF), MAP3K19 is upregulated and promotes TGF-β signaling, which is crucial in the disease's pathogenesis. Inhibition of MAP3K19 has shown potential in reducing fibrosis in experimental models (Boehme2016MAP3K19a). These findings highlight MAP3K19's clinical significance as a potential target for therapeutic intervention in various diseases.

## Interactions
MAP3K19 is involved in several protein interactions that play a crucial role in cellular signaling pathways. It phosphorylates MAP2Ks, specifically MEK1 and MKK7, leading to the activation of ERK and JNK pathways, which are essential for the survival of KRAS-mutant lung cancer cells (Hoang2020The). MAP3K19 does not directly phosphorylate ERK or JNK but acts upstream by activating their respective MAP2Ks (Hoang2020The).

In the context of TGF-β signaling, MAP3K19 regulates the nucleocytoplasmic shuttling of activated R-Smads, which are critical for TGF-β signaling. Inhibition of MAP3K19 results in decreased nuclear accumulation of phospho-Smad2/3, suggesting that MAP3K19 facilitates the nuclear import of these proteins (Boehme2016MAP3K19a). MAP3K19 may also interact with phosphatases like PPM1A and ubiquitin ligases such as Nedd4L, which are involved in the dephosphorylation and degradation of Smad proteins, although these interactions require further investigation (Boehme2016MAP3K19a).

MAP3K19 is also implicated in the activation of the NF-κB transcription factor, promoting the nuclear translocation of NF-κB subunits necessary for the transcriptional activation of pro-inflammatory genes (Boehme2016MAP3K19). These interactions highlight MAP3K19's role in mediating stress-induced inflammatory responses.


## References


[1. (Boehme2017P3.01054) Stefen Boehme, John Ludka, Danielle Ditirro, Tai Wei Ly, and Kevin Bacon. P3.01-054 antagonism of a novel kinase, map3k19, by specific small molecule inhibitors blocks human primary nsclc tumor growth in murine xenograft models. Journal of Thoracic Oncology, 12(1):S1152–S1153, January 2017. URL: http://dx.doi.org/10.1016/j.jtho.2016.11.1620, doi:10.1016/j.jtho.2016.11.1620. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jtho.2016.11.1620)

[2. (Hoang2020The) Van T. Hoang, Katherine Nyswaner, Pedro Torres-Ayuso, and John Brognard. The protein kinase map3k19 phosphorylates map2ks and thereby activates erk and jnk kinases and increases viability of kras-mutant lung cancer cells. Journal of Biological Chemistry, 295(25):8470–8479, June 2020. URL: http://dx.doi.org/10.1074/jbc.ra119.012365, doi:10.1074/jbc.ra119.012365. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra119.012365)

[3. (Liu2023CC) Wei Liu, Lei Wang, Jiajia Zhang, Kun Cheng, Wenming Zheng, and Zhenling Ma. Cc chemokine 2 promotes ovarian cancer progression through the mek/erk/map3k19 signaling pathway. International Journal of Molecular Sciences, 24(13):10652, June 2023. URL: http://dx.doi.org/10.3390/ijms241310652, doi:10.3390/ijms241310652. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms241310652)

[4. (Sandhu2023MAP3K19) Yuuki Sandhu, Norihiro Harada, Sonoko Harada, Takayasu Nishimaki, Hitoshi Sasano, Yuki Tanabe, Tomohito Takeshige, Kei Matsuno, Ayako Ishimori, Yoko Katsura, Jun Ito, Hisaya Akiba, and Kazuhisa Takahashi. Map3k19 affects tweak-induced response in cultured bronchial epithelial cells and regulates allergic airway inflammation in an asthma murine model. Current Issues in Molecular Biology, 45(11):8907–8924, November 2023. URL: http://dx.doi.org/10.3390/cimb45110559, doi:10.3390/cimb45110559. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cimb45110559)

[5. (Boehme2016MAP3K19) Stefen A. Boehme, Karin Franz-Bacon, John Ludka, Danielle N. DiTirro, Tai Wei Ly, and Kevin B. Bacon. Map3k19 is overexpressed in copd and is a central mediator of cigarette smoke-induced pulmonary inflammation and lower airway destruction. PLOS ONE, 11(12):e0167169, December 2016. URL: http://dx.doi.org/10.1371/journal.pone.0167169, doi:10.1371/journal.pone.0167169. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0167169)

[6. (Boehme2016MAP3K19a) Stefen A. Boehme, Karin Franz-Bacon, Danielle N. DiTirro, Tai Wei Ly, and Kevin B. Bacon. Map3k19 is a novel regulator of tgf-β signaling that impacts bleomycin-induced lung injury and pulmonary fibrosis. PLOS ONE, 11(5):e0154874, May 2016. URL: http://dx.doi.org/10.1371/journal.pone.0154874, doi:10.1371/journal.pone.0154874. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0154874)